l General Information |
Product Name | LY2886721 |
General description | LY2886721 is a BACE inhibitor used for the treatment of Alzheimer's Disease. |
Synonym | N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide |
Purity | ≥98.0%(HPLC) | CAS Number | 1262036-50-9 |
Formula | C18H16F2N4O2S | Molecular Weight | 390.41 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25℃) | DMSO | ≥5mg/mL |
Ethanol | Insoluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol
Actions | LY2886721 is a BACE inhibitor used for the treatment of Alzheimer's Disease. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
